Skip to main content Skip to main navigation menu Skip to site footer

Risk factors for increasing leprosy treatment dropout cases reported in specific areas in Tangerang District

Abstract

Link of Video Abstract: https://youtu.be/WPu8KQqNFNM

 

Introduction: In 2020, Indonesia announced the elimination of leprosy in the whole country, including the Banten Province, with new cases detected 568 cases (4.8 per 100,000 population), higher than the national average of 4.12 per 100,000 population. Although information on the percentage of dropouts in Indonesia is not known, it still occurs in the field, If the case is cleared out unchecked, it will become a source of transmission of wellbeing problems in the community. This study aims to determine the influence of socio-demographic factors, leprosy patients, and health services on leprosy dropout rates and detect new cases in the Panongan Community Health Center working area.

Methods:  Secondary data on leprosy patients at the Panongan Community Health Center during 2019-2022 and primary data from cross-sectional surveys through home visits, interviews, face-to-face, and screening. Screening for leprosy symptoms in close contact with the patient's family using a questionnaire that includes independent variables of socio-demographic, patient, and health center with the dependent variable of treatment dropout. Purposive sampling technique in 5 villages with leprosy cases. The total sample size was 79 people. Data were processed and analyzed using STATA 14.0.

Results: The logistic regression test was found to be significant (p-value < 0.05) including age, (p=0.003), occupation (p=0.002), stigma (p=0.001), family of leprosy patients (p=0.003), close contact (p=0,000), healthy eating habits (p=0.002),  perception of taking medicine (p=0.000) and a woman, 60 years old, was found to be infected with leprosy within the family of a drug withdrawal patient who was in near contact for 1 year, although multivariate testing was not statistically significant (p-value: > 0.05).

Conclusion: Increasing compliance through health education and motivation of patients and families, also monitoring medication taking by health service staff, groups of former patients, and cadres.

References

  1. Kementerian Kesehatan Republik Indonesia. Profil Kesehatan Indonesia 2021. 2021.
  2. Kementerian Kesehatan Republik Indonesia. Permenkes No 11 tahun 2019 Tentang Penanggulangan Kusta. 2019.
  3. World Health Organization. Towards zero leprosy. Global leprosy (‎Hansen’s Disease)‎ strategy 2021–2030 [Internet]. 2021. Available from: https://www.who.int/publications/i/item/9789290228509
  4. Madhivanan A, Venugopal V, Dongre A. Physical violence against doctors: A content analysis from online Indian newspapers. Vol. 45, Indian Journal of Community Medicine. Wolters Kluwer Medknow Publications; 2020. p. 108–9.
  5. Dinas Kesehatan Provinsi Banten. Profil Kesehatan Provinsi Banten 2021 [Internet]. 2021. Available from: https://dinkes.bantenprov.go.id/pages/438d06a6-6b96-4a60-ab38-afa24684bf15/profil-kesehatan-provinsi-banten-tahun-20212/4
  6. Bur N, Amelia AR, Nurgahayu N. Analisis Faktor yang Berhubungan dengan Kepatuhan Berobat Mantan Pasien Kusta. Window of Health. 2018;1.
  7. Agustin Fatmala K. Analysis of Factors Related with Compliance Taking Medicine of Leprosy in District Pragaan. J Berk Epidemiol. 2016;4(1):1–13.
  8. Apri A, Suki F, Pakan PD, Kartikahadi AD. Analisis Faktor yang Mempengaruhi Kepatuhan Minum Obat Pada Penderita Kusta di Kota Kupang Tahun 2017. Vol. 15, Analisis Faktor Yang Mempengaruhi Cendana Medical Journal. 2018.
  9. Liyanage NR, Arnold M, Wijesinghe MSD. Factors associated with treatment defaulting among adult leprosy patients in Sri Lanka: a case-control study. Lepr Rev. 2021;92(3):247–59. Available from: http://dx.doi.org/10.47276/lr.92.3.247
  10. Rivera Chavarría A, Sánchez Hernández G, Espinoza Aguirre A. Factors influencing adherence to treatment among people with leprosy in Costa Rica. Lepr Rev. 2023;94(3):208–17. Available from: http://dx.doi.org/10.47276/lr.94.3.208
  11. Bhat L, Khan N, Vaida N, Hassan I, Tariq Banday M. Prevalence, Characteristics and Socio-Demographic Correlates of Self-Stigma among Leprosy Affected Persons-A Case Study [Internet]. Vol. 2023, Indian J Lepr. Available from: http://www.ijl.org.in
  12. Saraswat N, Agarwal R, Chopra A, Kumar S, Dhillon A, Agarwal R. Assessment of Factors Responsible for Dropout to Multi Drug Therapy for Leprosy [Internet]. Vol. 91, Indian J Lepr. 2019. Available from: http://www.ijl.org.in
  13. Dharmawan Y, Fuady A, Korfage I, Richardus JH. Individual and community factors determining delayed leprosy case detection: A systematic review. PLoS Negl Trop Dis. 2021;15(8):e0009651–e0009651. Available from: https://pubmed.ncbi.nlm.nih.gov/34383768
  14. Giantoro M. Faktor-faktor yang Berhubungan dengan Tingkat Kepatuhan Minum Obat Penderita Kusta di Puskesmas Pasir Panjang dan Puskesmas Alak di Kota Kupang, Indonesia. CDK-276. 2019;46(5).
  15. Umniyati H, Zahroh H, Yuliwulandari R. Determinant Factors That Affect the Quality of Life of People with Leprosy in Sumenep, Indonesia. Malaysian Journal of Public Health Medicine. 2022;2022(1):146–53.
  16. Maziyya N, Mariyanti H. Quality of Life of Leprosy Patients Based on Health Belief Models (HBM) Theory. INDONESIAN NURSING JOURNAL OF EDUCATION AND CLINIC (INJEC). 2016;1(1).
  17. Adriaty D, Sp CR, Iswahyudi, Wahyuni R, Agusni I, Izumi S. Leprosy transmission in endemic and non-endemic areas based on the profile of antibody response of PGL-1 and PCR detection of Mycobacterium leprae DNA from nasal swab among healthy children of East Java, Indonesia. Infect Dis Rep. 2020;12(Suppl 1):8748. Available from: https://pubmed.ncbi.nlm.nih.gov/32874474
  18. Sonthalia S, Agrawal M, Sehgal VN. Topical Ciclopirox Olamine 1%: Revisiting a Unique Antifungal. Indian Dermatol Online J. 2019;10(4):481–5. Available from: https://pubmed.ncbi.nlm.nih.gov/31334080
  19. Nasir A, Yusuf A, Listiawan MY, Makhfudli M. The life experience of leprosy families in maintaining interaction patterns in the family to support healing in leprosy patients in Indonesian society. A phenomenological qualitative study. PLoS Negl Trop Dis. 2022;16(4):e0010264–e0010264. Available from: https://pubmed.ncbi.nlm.nih.gov/35394998
  20. van ’t Noordende AT, Lisam S, Singh V, Sadiq A, Agarwal A, Hinders DC, et al. Changing perception and improving knowledge of leprosy: An intervention study in Uttar Pradesh, India. PLoS Negl Trop Dis. 2021;15(8):e0009654–e0009654. Available from: https://pubmed.ncbi.nlm.nih.gov/34424909
  21. Bacan B, Yudanagara H. Dampak Psikososial Diskriminasi Pada Mantan Penderita Kusta. Jurnal Psikologi : Media Ilmiah Psikologi. 2020;18.
  22. Jariyakulwong N, Julanon N, Saengboonmee C. Lepromatous leprosy with a suspected 30-year incubation period: A case report of a practically eradicated area. J Taibah Univ Med Sci. 2022;17(4):602–5. Available from: https://pubmed.ncbi.nlm.nih.gov/35983441
  23. Akbar H. Faktor Risiko Kejadian Kusta di Wilayah Kerja Puskesmas Juntinyuat. Jurnal Wiyata: Penelitian Sains dan Kesehatan. 2020;7(1).
  24. Andreas C, Horidah H, Sulistiana R, Venosia D. Modeling the prevalence of leprosy in East Java using a geographic weighted regression approach. 2018;33–48. 2018.
  25. Afifah N, Ilmu J, Masyarakat K, Keolahragaan I. Pengobatan Penderita Kusta Tipe MB [Internet]. Vol. 3, Unnes Journal of Public Health. 2014. Available from: http://journal.unnes.ac.id/sju/index.php/ujph
  26. Cisneros J, Ferreira JA, de Faria Grossi MA, de Filippis T, de Oliveira ALG, Lyon S, et al. Associations between occupation, leprosy disability and other sociodemographic factors in an endemic area of Brazil. PLOS global public health. 2022;2(9):e0000276–e0000276. Available from: https://pubmed.ncbi.nlm.nih.gov/36962742

How to Cite

Sity Kunarisasi, Jatty Puspaningtias, & Farah Segeir. (2023). Risk factors for increasing leprosy treatment dropout cases reported in specific areas in Tangerang District. Bali Medical Journal, 13(1), 216–222. https://doi.org/10.15562/bmj.v13i1.4894

HTML
11

Total
4

Share

Search Panel